Doctors Blast Rosy Research For Medtronic Bone Device
The authors of 13 industry-sponsored studies on Medtronic Inc.'s bone-growth device Infuse downplayed serious risks related to the product and failed to adequately — if at all — disclose their financial...To view the full article, register now.
Already a subscriber? Click here to view full article